Ethanethioic acid,S-(31,31-diphenyl-12,15,18,21,24,27,30-heptaoxahentriacont-1-yl)ester (501368-83-8)

Identification
Name:	Ethanethioic acid,S-(31,31-diphenyl-12,15,18,21,24,27,30-heptaoxahentriacont-1-yl)ester
CAS:	501368-83-8
Molecular Formula:	C₃₈H₆₀O₈S
Molecular Structure:
Properties
Safety Data

Other Product

Ethanethioic acid,S-(31-phenyl-12,15,18,21,24,27,30-heptaoxahentriacont-1-yl) ester
1/C33H42O7/c1-19-25-17-24-18-27(39-22(4)35)20(2)29(32(24,5)6)30(37)31(33(25,7)16-15-26(19)38-21(3)34)40-28(36)14-13-23-11-9-8-10-12-23/h8-14,24-27,30-31,37H,1,15-18H2,2-7H3/b14-13+/t24-,25-,26+,27+,30-,31+,33-/m1/s
1/C27H27N3O3S/c1-30-25(20-11-15-23(33-3)16-12-20)24(19-9-13-22(32-2)14-10-19)29-27(30)34-18-17-28-26(31)21-7-5-4-6-8-21/h4-16H,17-18H2,1-3H3,(H,28,31
1/C51H74N2/c1-5-9-13-17-21-49(22-18-14-10-6-2)42-53(43-50(23-19-15-11-7-3)24-20-16-12-8-4)51-39-37-47(38-40-51)32-31-45-27-25-44(26-28-45)29-30-46-33-35-48(41-52)36-34-46/h25-40,49-50H,5-24,42-43H2,1-4H3/b30-29+,32-31
1/C28H41N5O15S.Na/c1-12(2)21(28(42)43)33-26(41)17(9-15-5-7-16(8-6-15)48-49(44,45)46)31-25(40)18(29-13(3)35)10-20(37)32-27-22(30-14(4)36)24(39)23(38)19(11-34)47-27;/h5-8,12,17-19,21-24,27,34,38-39H,9-11H2,1-4H3,(H,29,35)(H,30,36)(H,31,40)(H,32,37)(H,33,41
24(31)-Dehydrocarboxyacetylquercinic acid
Viscotoxin A3 (reduced), 5-L-arginine-8-L-tryptophan-9-L-alanine-12-L-cysteine-15-L-valine-19-L-proline-21-L-threonine-22-L-isoleucine-22a-endo-L-serine-24-L-glutamic acid-25-L-isoleucine-29-L-lysine-30-L-cysteine-31-L-aspartic acid-38-L-threonine-42a-endo-L-aspartic acid-45-de-L-aspartic acid-
4,8,12,16,20,24,28-Heptaazahentriacontanoic acid,31-amino-15-(4-aminobutyl)-7-(hydroxymethyl)-31-(1H-imidazol-4-yl)-3-(mercaptomethyl)-27-methyl-18,23-bis(1-methylethyl)-11-(2-methylpropyl)-5,9,13,17,21,25,29-heptaoxo-,(3R,7S,11S,15S,18S,23R,27R,31R)-
4,8,12,16,20,24,28-Heptaazahentriacontanoic acid,31-amino-15-(4-aminobutyl)-7-(hydroxymethyl)-31-(1H-imidazol-4-yl)-3-(mercaptomethyl)-27-methyl-18,23-bis(1-methylethyl)-11-(2-methylpropyl)-5,9,13,17,21,25,29-heptaoxo-,(3R,7S,11S,15S,18S,23R,27R,31R)-, tr
4,8,12,16,20,24,28-Heptaazahentriacontanoic acid,31-amino-15-(4-aminobutyl)-7-(hydroxymethyl)-31-(1H-imidazol-4-yl)-3-(mercaptomethyl)-27-methyl-18,23-bis(1-methylethyl)-11-(2-methylpropyl)-5,9,13,17,21,25,29-heptaoxo-,(3R,7S,11S,15S,18S,23R,27R,31R)-, pe
31-Oxa-2,8,13,19,24,30-hexaazanonatriacontanoic acid,30-acetyl-9,12,20,23,32-pentaoxo-8,19-bis[(1-oxooctyl)oxy]-, ethyl ester
11-benzyl-4-(butan-2-yl)-7,21,25-trimethyl-18-(2-methylpropyl)-6,20-dioxa-13,27-dithia-3,10,17,24,29,30,31,32-octaazapentacyclo[24.2.1.1~5,8~.1~12,15~.1~19,22~]dotriaconta-1(28),5(32),12(31),14,19(30),26(29)-hexaene-2,9,16,23-tetrone
b-Endorphin (sheep),18-L-tyrosine-27-L-tryptophan-31-L-glutamic acid- (9CI)
6-Oxa-13,26-dithia-3,10,17,20,23,28,29,30-octaazatetracyclo[23.2.1.15,8.112,15]triaconta-5(30),12(29),14,25(28),27-pentaene-2,9,16,19,22-pentone,21-[1-(formyloxy)ethyl]-7,11-dimethyl-18-(1-methylpropyl)-4-(2-methylpropyl)-24-(phenylmethyl)-(9CI)
Formamide,N-[11-[16-(acetyloxy)-12-hydroxy-10,22-dimethoxy-11,14,21-trimethyl-18-oxo-3,7,19,27-tetraoxa-29,30,31-triazatetracyclo[24.2.1.12,5.16,9]hentriaconta-2(31),4,6(30),8,24,26(29),28-heptaen-20-yl]-4,10-dimethoxy-3,5,9-trimethyl-6-oxo-1-undecenyl]-N-methyl-(9CI)
1/C26H18O2/c1-17-16-23-21-9-5-3-7-19(21)11-13-25(23)28-26(17)15-14-22-20-8-4-2-6-18(20)10-12-24(22)27-26/h2-16H,1H
1/C21H26N2O4/c1-3-14-8-9-19(25)23(12-14)11-10-16-15-6-4-5-7-18(15)22-20(16)17(13-24)21(26)27-2/h4-7,12,17,22,24H,3,8-11,13H2,1-2H
Formamide,N-[11-[16-[(aminocarbonyl)oxy]- 12-hydroxy-10,22-dimethoxy-11,14,21- trimethyl-18-oxo-3,7,19,27-tetraoxa-29,30,- 31-triazatetracyclo[24.2.1.12,5.16,9]hentriaconta- 2(31),4,6(30),8,24,26(29),28-heptaen-20-yl]-4,- 10-dimethoxy-3,5,9-trimethyl-6-oxo-1- undecenyl]-N-methyl-
31-Oxa-2,8,13,19,24,30-hexaazanonatriacontanoic acid,30-acetyl-9,12,20,23,32-pentaoxo-8,19-bis[(1-oxooctyl)oxy]-,1,1-dimethylethyl ester
1/C22H28O6/c1-23-17-11-21(27-5)19(25-3)9-15(17)13-7-8-14(13)16-10-20(26-4)22(28-6)12-18(16)24-2/h9-14H,7-8H2,1-6H3/t13-,14